指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

ICU中流感与SARS-CoV-2下一波管理:CAPA/IAPA患者实用推荐

Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients.
指南 / 共识 · J Fungi (Basel) · 2023-03-02
一句话结论CAPA/IAPA专家组的实用推荐:诊断和治疗应基于现有证据和CAPA管理经验,但支持证据非常有限。

本文为CAPA/IAPA专家组制定的实用推荐,旨在为流感相关侵袭性肺曲霉病(IAPA)和COVID-19相关肺曲霉病(CAPA)的诊断与治疗提供指导。专家组定义了14个领域,采用PICO策略在PubMed检索CAPA和IAPA证据,各专家基于结果制定2-3个领域的推荐并经多次会议达成共识。最终推荐分为12个部分,涵盖怀疑真菌感染的时机、诊断方法、治疗推荐、耐药处理、药物相互作用或抗真菌药物浓度测定、疗效监测、治疗失败处理、合并使用皮质类固醇的影响、抗真菌药物联合使用指征、停药时机、严重病毒性肺炎患者曲霉培养阳性或定植的处理以及抗真菌预防的地位。支持CAPA/IAPA实用管理的现有证据非常稀少,CAPA管理经验对IAPA管理可能非常有用。

要点

  • CAPA/IAPA专家组的实用推荐涵盖12个部分,包括怀疑真菌感染的时机、诊断方法、治疗推荐、耐药处理、药物相互作用或抗真菌药物浓度测定、疗效监测、治疗失败处理、合并使用皮质类固醇的影响、抗真菌药物联合使用指征、停药时机、曲霉培养阳性或定植的处理以及抗真菌预防。
  • 支持CAPA/IAPA患者实用管理的现有证据非常稀少。
  • 在CAPA患者管理中积累的经验对IAPA患者的管理可能非常有用。
  • 专家组基于PICO策略在PubMed检索CAPA和IAPA证据,各专家制定2-3个领域的推荐并经多次会议达成共识。
  • 专家组定义了14个领域,最终推荐分为12个部分。

适用人群与场景

  • ICU中流感相关侵袭性肺曲霉病(IAPA)患者
  • ICU中COVID-19相关肺曲霉病(CAPA)患者

研究设计与关键结果

  • 制定机构:CAPA/IAPA专家组;方法:定义14个领域,采用PICO策略在PubMed检索CAPA和IAPA证据,各专家基于结果制定2-3个领域的推荐,经多次会议达成共识;最终推荐分为12个部分,涵盖怀疑真菌感染的时机、诊断方法、治疗推荐、耐药处理、药物相互作用或抗真菌药物浓度测定、疗效监测、治疗失败处理、合并使用皮质类固醇的影响、抗真菌药物联合使用指征、停药时机、严重病毒性肺炎患者曲霉培养阳性或曲霉定植的处理以及抗真菌预防的地位。

证据类型、等级与局限

  • 证据类型:专家共识;支持CAPA/IAPA患者实用管理的现有证据非常稀少。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,在CAPA患者管理中积累的经验对IAPA患者的管理可能非常有用。

指南或共识出处

  • 指南名称:Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients;发布机构:CAPA/IAPA专家组;期刊:J Fungi (Basel)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The aim of this study was to establish practical recommendations for the diagnosis and treatment of influenza-associated invasive aspergillosis (IAPA) based on the available evidence and experience acquired in the management of patients with COVID-19-associated pulmonary aspergillosis (CAPA). The CAPA/IAPA expert group defined 14 areas in which recommendations would be made. To search for evidence, the PICO strategy was used for both CAPA and IAPA in PubMed, using MeSH terms in combination with free text. Based on the results, each expert developed recommendations for two to three areas that they presented to the rest of the group in various meetings in order to reach consensus. As results, the practical recommendations for the management of CAPA/IAPA patients have been grouped into 12 sections. These recommendations are presented for both entities in the following situations: when to suspect fungal infection; what diagnostic methods are useful to diagnose these two entities; what treatment is recommended; what to do in case of resistance; drug interactions or determination of antifungal levels; how to monitor treatment effectiveness; what action to take in the event of treatment failure; the implications of concomitant corticosteroid administration; indications for the combined use of antifungals; when to withdraw treatment; what to do in case of positive cultures for Aspergillus spp. in a patient with severe viral pneumonia or Aspergillus colonization; and how to position antifungal prophylaxis in these patients. Available evidence to support the practical management of CAPA/IAPA patients is very scarce. Accumulated experience acquired in the management of CAPA patients can be very useful for the management of IAPA patients. The expert group presents eminently practical recommendations for the management of CAPA/IAPA patients.

来源:J Fungi (Basel),查看原文。版权归原作者所有。

参考来源

  1. Peral J, Estella Á, Nuvials X, et al. Managing the Next Wave of Influenza and/or SARS-CoV-2 in the ICU-Practical Recommendations from an Expert Group for CAPA/IAPA Patients. J Fungi (Basel). 2023. PMID: 36983480. doi:10.3390/jof9030312

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。